As mechanistic insights deepen and novel targeting strategies mature, IQGAP1-based interventions may emerge as powerful tools in addressing unmet clinical needs across cancer, metabolic disorders, immune dysregulation, and beyond. The gene discussed is IQGAP1; the disease is metabolic disease.